Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 20

Go back to Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 20

Zevra Therapeutics (ZVRA) announces CFO Resignation

November 20, 2025 4:32 PM EST

On November 20, 2025, R. LaDuane Clifton, the Chief Financial Officer and Treasurer and principal financial officer of Zevra Therapeutics (NASDAQ: ZVRA) notified the Company of his decision to resign from his position, effective December 31, 2025 (the Separation Date), in order to pursue other professional opportunities.

... More